#disease
Latest news and interesting information about disease.
Biotech at Inflection Point: JPMorgan Covers 14 Firms | Bond.az
JPMorgan covers 14 biotech firms at inflection point, with ratings and price targets. See which companies are poised for growth and the catalysts ahead.
Real chocolate makes a comeback
Cocoa price slump since 2024 makes real chocolate more profitable. Hershey reverts to original recipes. Discover the shift back to traditional chocolate and its impact on farmers and consumers.
US doctor in contact with Ebola patient heading to Czech hospital
A US doctor exposed to Ebola is being transferred from Uganda to a Czech hospital as a precaution. Officials assure no risk to the public.
Air pollution is second leading cause of death
UN official Anna Soave says air pollution is the second leading cause of death globally. 7 million people die annually from it.
H.C. Wainwright reiterates MindWalk stock rating on platform validation
H.C. Wainwright reiterates Buy rating and $5 target on MindWalk stock, citing platform validation and strong pipeline. Read more.
Jefferies Initiates SAB Biotherapeutics with Buy
Jefferies initiates coverage on SAB Biotherapeutics with a Buy rating and $11 target, focusing on SAB-142 diabetes therapy.
Double Danger for Heart Patients: Hantavirus
Hantavirus poses serious risks for heart patients. Cardiologist Alexandro Croquer explains complications and myocardiopathy risks.
MeiraGTx CEO Forbes Alexandria sells $568,540 in shares
MeiraGTx CEO Forbes Alexandria sells $568,540 in shares. The stock has returned 66% over the past year but faces profitability challenges.
14-year-old girl fooled everyone for 1.5 years
A 14-year-old Moscow girl pretended to be terminally ill for 1.5 years, fooling everyone. She self-harmed to avoid school.
Relay Therapeutics Launches $175M Stock Offering
Relay Therapeutics launches $175 million stock offering. See details on the offering, zovegalisib progress, and analyst ratings. Bond.az covers the latest.
Ebola patient moved to Germany for treatment
Germany prepares to treat a U.S. citizen with Ebola from DRC. Read more on Bond.az.
Genentech to Present Breast Cancer Data at ASCO Meeting
Genentech will present breast cancer data on giredestrant and other drugs at the 2026 ASCO meeting.
BofA raises Candel price target to $9
BofA raises Candel price target to $9 after 39% improvement in prostate cancer survival data.
US CDC confirms one American tests positive for Ebola
US CDC confirms one American tested positive for Ebola. Patient to be transferred to Germany for treatment. Risk to US remains low.
Hantavirus cruise ship docks in Rotterdam
The MV Hondius cruise ship with hantavirus outbreak arrives in Rotterdam. Quarantine and disinfection procedures underway.
WHO rejects Taiwan participation in annual assembly
WHO member states reject Taiwan's participation in the annual assembly after China's objection.
7 million manat for foot-and-mouth vaccine
Azerbaijan allocates 6.7 million manat for foot-and-mouth disease vaccines. The Agrarian Services Agency will procure 5.38 million doses.
LAM-001 Phase 2a Data in PH-ILD
Quince Therapeutics reports Phase 2a results for LAM-001 in PH-ILD: 67.4-meter improvement in six-minute walk distance.
Congo Ebola outbreak: Health workers race to frontlines
Congo Ebola outbreak spreads rapidly. Health workers race to frontlines. WHO declares emergency. Latest updates on Bond.az.
US anti-vaccine bills fail as health groups lobby lawmakers
US anti-vaccine bills fail as public health groups lobby Republican lawmakers. School vaccine mandates survive. Learn more on Bond.az.
Rare, untreatable Ebola strain - global emergency
WHO declares global emergency over rare, untreatable Bundibugyo Ebola strain. Outbreak spreads in Congo and Uganda, no approved vaccine or treatment.
New Ebola outbreak in Congo: 80 dead
A new Ebola outbreak in Congo's Ituri province has killed at least 80 people. The new strain may resist existing vaccines.
Rat Hepatitis E Detected in Hong Kong
Hong Kong reports first human case of rat hepatitis E in 2026. 42-year-old patient discharged. Investigation ongoing.
Handshake can spread these diseases
Russian doctor warns that handshakes can transmit salmonellosis, rotavirus, and fungal infections. Learn how to protect yourself with proper hygiene.
Amgen stock falls on Tavneos liver risk
Amgen shares drop 2.1% as Tavneos liver risks emerge. FDA and EMA take action. Kissei reports 20 deaths in Japan.
Atisama advances RB042 trial, appoints Bernard Coulie as chair
Atisama advances Phase 1 trial of RB042 and appoints Dr. Bernard Coulie as Board Chair. The drug shows safety; higher-dose results due in H2 2026.
How long does hantavirus survive at room temperature?
Learn about hantavirus survival at room temperature, transmission, and prevention.
Piper Sandler Raises Biogen Target to $225
Piper Sandler raises Biogen price target to $225 from $214. Phase II trial of BIIB080 missed primary endpoint but showed slowing of clinical decline at lowest dose.
"Wegovy" aids weight loss in menopause
"Wegovy" effectively supports weight loss and heart health in menopausal women.
Biogen Stock: Alzheimer Drug Shows Promise
Biogen's Alzheimer drug diranersen shows positive Phase 2 results. Stock analysis and future outlook from Bond.az.
...